Find the Perfect Plan for Your Investment Journey
Last Price
52 Week Range
$18.35 - $35.00
Next Earnings Date
May 08 2025
Next Earnings Date
May 08 2025
Last Price
Market Cap | $291.41M |
EV | $305.48M |
Shares Outstanding | 12.31M |
Beta | 1.00 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $64.67 |
P/E 2025E | - |
P/Revenue 2025E | 8.85x |
Revenue | -9.30% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | 34.90% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | -19.57% |
ROE 2025E | - |
ROCE 2024 | -22.63% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
XOMA Royalty Corporation
XOMA
Sector
Healthcare
Industry
Biotechnology
CEO
Hughes, Owen
Employees
13
Website
xoma.comIPO Date
1986-06-06
Headquarters
2200 Powell Street, Suite 310, EmeryVille, California, 94608, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved